ROBERT E. PAYNE, Senior District Judge.
This consolidated securities fraud action is before the Court on two motions seeking appointment as lead plaintiffs and lead counsel under 15 U.S. C. § 78u-4, the Private Securities Litigation Reform Act ("PLSRA"). All of the Plaintiffs in this consolidated action agree that Plaintiffs Alexander Rice and Brian James ought to be appointed as lead plaintiffs and that their counsel should be appointed as lead counsel.
The underlying facts are taken from the COMPLAINT (ECF No. 1) filed by Alexander Rice. The facts, as alleged, are recited as they have been pled, and, for now, they are taken as true. The procedural history is reflected as it developed.
Genworth Financial Incorporated ("the Company" or "Genworth") provides consumers with mortgage insurance products that allow people to purchase homes. The Company also offers services ranging from homeownership education and assistance programs to individual and group long-term care insurance products." (Compl. ¶ 36) (ECF No. 1). For several years, the Company's financial circumstances were dire.
"In or around May 2015, the Company received a written proposal to acquire the Company's stock in an all cash transaction at $12.50 per share, a proposal that was later reduced to between $10-11 per share."
On October 21, 2016, a Merger Agreement was executed between Genworth and China Oceanwide.
On December 21, 2016, the Company filed a Schedule 14A Preliminary Proxy Statement ("Proxy Statement") with the Securities and Exchange Commission ("SEC").
On January 23, 2017, Alexander Rice ("Rice") filed a Class Action Complaint (the "Complaint"), in which he raised claims under Sections 14(a) and 20(a) of the Securities Exchange Act of 1934. The Complaint alleges that "[t] he Merger Consideration and the process by which Defendants agreed to consummate the Proposed Transaction are fundamentally unfair to Genworth's public stockholders as the Merger Consideration represents only a 4.2% premium to the Company's closing price of $5.21 on October 21, 2016, the last trading day before the Proposed Transaction was announced." (Compl. ¶ 5). "Despite Genworth's prospects for future profitability and growth and Defendants' ability to command a higher transaction value, Defendants chose to enter into the Merger Agreement with China Oceanwide and agreed to onerous deal provisions and other agreements to ensure and protect a sale only to China Oceanwide."
The Complaint filed by Rice alleges several material misrepresentations and omissions in the Proxy Statement provided to Genworth shareholders.
On January 25, 2017, the Company filed a Schedule 14A Definitive Proxy Statement with the SEC. This Proxy Statement recommended that shareholders vote in favor of the Proposed Transaction and announced that the special shareholder meeting to vote on the Proposed Transaction would occur on March 7, 2017.
On January 25, 2017, Brian James ("James") filed a Class Action Complaint for Violations of Sections 14 (a) and 20 (a) of the Securities Exchange Act of 1934, in which he raised essentially the same substantive claims as those raised by Rice. Rice and James agreed to work together to coordinate their actions. Also on January 25, 2017, the Rosenfeld Family Trust filed a Class Action Complaint in the United States District Court for the District of Delaware, in which it raised substantively similar claims to those raised by Plaintiffs Rice and James.
On February 6, 2017, Esther Chopp ("Chopp") filed a Class Action Complaint in the United States District Court for the District of Delaware. Chopp raised essentially the same substantive claims as raised by Rice and James.
On February 10, 2017, David Ratliff filed in the United States District Court for the Eastern District of Virginia a complaint in which he raised substantively identical claims to those already raised by Rice, James, and the Rosenfeld Family Trust. The Ratliff case was filed and identified as a case related to the Rice case.
On February 17, 2017, an Emergency Motion to Consolidate Cases and for Appointment of Interim Lead Counsel was filed, in which Rice and James sought the entry of an order consolidating the actions pending before this Court, and appointing Faruqi & Faruqi, LLP, Monteverde & Associates, PC, and Kahn Swick & Foti, LLC ("KSF") as Interim Class Counsel and MeyerGoergen PC as Interim Lead Liaison Counsel. (ECF No. 22). The Court determined that "all three actions [Rice, James & Ratliff] shall be consolidated and the caption of the consolidated case shall be
The Plaintiffs subsequently reached an agreement with the Defendants, pursuant to which the Motion for a Preliminary Injunction was withdrawn. Also, the parties in this consolidated action advised "that it is their intent that following [Defendant's] disclosures called for in Court Exhibit 1, these consolidated actions will be settled in their entirety and, to that end, counsel intend to prepare a Memorandum of Understanding reflecting the settlement (including releases); and, to that end, counsel shall prepare a schedule of further proceedings respecting class certification and appointment of counsel all of which shall comply with the timing requirements of the Private Securities Litigation Reform Act." (ECF No. 30).
On March 6, 2016, the Court entered the STIPULATED PSLRA LEAD PLAINTIFF SCHEDULING ORDER. (ECF No. 35). It provided that: "[p]ursuant to 15 U.S.C. § 78u-4 (a) (3) (A), on or before April 17, 2017, any plaintiff in these actions or any other member of the purported class who wishes to serve as lead plaintiff in this consolidated purported class action shall file a motion to serve as lead plaintiff of the purported class and shall state its selection for lead counsel to represent the purported class, subject to approval by the Court."
On April 1, 2017, the Union filed its motion seeking to be named lead plaintiff and seeking approval of the Union's counsel as lead counsel. (ECF No. 37). Rice and James, with the consent of the other plaintiffs in the consolidated cases, also filed the PLAINTIFFS' MOTION FOR APPOINTMENT OF LEAD PLAINTIFFS ANO COUNSEL. (ECF No. 39).
The Union also has a shareholder derivative action pending in the Delaware Court of Chancery,
The stockholder vote has taken place and the merger was approved; however, the merger of Genworth and China Oceanwide has been pending for several months. Recently, a further delay in the merger was announced.
Pursuant to the PSLRA, the Court must appoint the "most adequate plaintiff" to serve as Lead Plaintiff. 15 U.S.C. § 78u-4 (a) (3) (B) (i). To that end, explains the Union, the Court is required to determine which potential lead plaintiff has the "largest financial interest" in the relief sought by the Class and whether that plaintiff is a typical and adequate class representative under Rule 23 of the Federal Rules of Civil Procedure. The Union argues that, of the shareholders involved in these motions, it has the largest financial interest, and that, therefore, there is a presumption that it should be the lead plaintiff
Rice and James concede that, of the shareholders involved in these motions, the Union has the largest financial interest in Genworth. Although Rice and James acknowledge that, under the PSLRA, the Union is deemed the presumptive lead plaintiff, they take the view that the Union cannot adequately represent the class based "on the conflict the [Union] has due to its simultaneous prosecution of derivative claims for Genworth and based on its failure to pursue shareholder direct claims as the Rice Group has." (ECF No. 50). In particular, Rice and James maintain that the Union's derivative claim against Genworth in Delaware presents a conflict of interest and subjects the Union to unique defenses, thereby rendering the Union an inadequate lead plaintiff.
Rice and James further explain that the conflict will continue even after the merger is completed (if it is completed). "There are other scenarios where the derivative case goes on for years, keeping the IUOE Investor Group in a conflicted position. For example, the approval of the Merger could be delayed for over a year, or new evidence could trigger an exception to the mootness rule and the derivative claims could go on after approval of the Merger. . . ."
In response, the Union argues that there is no conflict because this action and the derivate action in Delaware are related. "In the Derivative Action, the IUOE Investor Group alleges that certain Genworth Financial, Inc. [] executives and directors breached their fiduciary duties by allowing Genworth to engage in securities fraud . . . [and here) the Rice Group is alleging, inter alia, that defendants failed to properly value the derivative claims asserted by the IUOE Investor Group and disclose all material information regarding those claims."
In response to the Court's inquiry, all parties agree that the case is not moot, notwithstanding the settlement of the preliminary injunction aspect of the case and the amended disclosures made by the Company pursuant to the settlement. Rice and James argue that the existence of a settlement does not divest the Court's jurisdiction over the case, but does have a bearing on the lead plaintiff analysis.
On July 5, 2017, at the hearing on the lead plaintiff/lead counsel motions, the Company weighed in on that issue by arguing that there was no merit to the securities claims that the Union says it would raise if it were appointed lead counsel. The Court gave the parties an opportunity to brief that argument. The Union responded that the Company had no right to argue a position on the lead plaintiff motions. Rice and James essentially adopted the argument advanced by the Company.
"Although neither party has affirmatively argued that the case is moot, resolution of that question is nonetheless essential because, if the case is moot, the Court lacks jurisdiction to proceed further and any opinion would be advisory and thus improper."
The inquiry to be made here is much like the one presented in
Here, as in
Considering the facts in this record, the Court concludes that the case is not moot and that the Court retains jurisdiction over the case. Thus, it is appropriate now to consider the motions respecting the designation of lead plaintiff and lead counsel.
"[T] he PSLRA provides a sequential procedure for litigants and the district court to follow in determining who among the members of the alleged class is the `most adequate plaintiff' to serve as the lead plaintiff for the consolidated class action. The PSLRA also provides certain specific requirements that a candidate must meet to be named lead plaintiff."
Pursuant to 15 U.S.C. § 78u-4 (a) (3) (B) (i), "[n]ot later than 90 days after the date on which a notice is published under subparagraph (A) (i), the court shall consider any motion made by a purported class member in response to the notice, including any motion by a class member who is not individually named as a plaintiff in the complaint or complaints, and shall appoint as lead plaintiff the member or members of the purported plaintiff class that the court determines to be most capable of adequately representing the interests of class members (hereafter in this paragraph referred to as the "most adequate plaintiff"). . . ." On March 6, 2017, the Court ordered the parties to file their Lead Plaintiff Notice in compliance with the PSLRA.
The IUOE holds 39,153 shares of Genworth common stock. Rice and James concede that, of the shareholders involved in these motions, the IUOE holds the largest financial interest in the litigation. Rice and James collectively own 17,223 shares of Genworth stock. Rice owns 100 shares. James owns 17,123 shares.
"Even if a candidate has the largest financial interest in a case, it is not the presumptive Lead Plaintiff unless it `otherwise satisfies the requirements of Rule 23 of the Federal Rules of Civil Procedure.' 15 U.S.C. § 78u 4 (a) (3) (B) (iii) (I) (cc)."
Originally, Rice and James did not challenge the Union's position on typicality and the capacity for adequate represenation at this stage of the litigation.
See (ECF No. 73).
The Court agrees with the Union that the Company cannot be the party to contest whether the Union can rebut the presumption of the Union's adequacy. Under the PSLRA, that prerogative lies with "a member of the purported plaintiff class" can offer evidence rebutting the lead plaintiff presumption.
However, the argument raised by the Company, and subsequently adopted by Rice and James, is applicable to the relaxed Rule 23 analysis and the Company is entitled to weigh in on that issue. Therefore, "[t]he Court will consider the argument by the [Company] that the [Union] do[es] not . . . satisf[y] the requirements of Rule 23 of the Federal Rules of Civil Procedure."
As explained earlier, "[a] wide ranging analysis under Rule 23 is not appropriate at this initial stage of the litigation and should be left for the Court's later consideration of a motion for class certification."
The Union argues that, without regard to its specific knowledge or votes, it has standing to pursue the§ 14(a) claims because "[it was] harmed when Defendants issued a misleading proxy that caused Genworth shareholders to approve a merger for $2.7 billion when the truth was that Genworth was worth at least $2.939 billion." (ECF No. 70). In
The same is true in this case. Whether the Union relied on the proxy statement in making its vote,
"The above presumption [insofar of the entity with the largest financial interest] may only be rebutted by proof that the presumptive lead plaintiff (1) will not fairly and adequately protect the interests of the class or (2) is subject to `unique defenses' that render such plaintiff incapable of adequately representing the class.
Rice and James argue that the Union has a conflict of interest in representing the class. Therefore, Rice and James contend that the Union cannot fairly and adequately represent the class.
To rebut the presumption that the Union is not an adequate lead plaintiff, Rice and James contend that the Union has a conflict of interest in this action
Rice and James assert the following conflicts based on the Union's prosecution of the derivative action:
The Fourth Circuit has not determined whether a plaintiff pursuing a derivative action on behalf of a corporation in one case is per se conflicted when also pursuing a direct action against the corporation in a separate case as lead plaintiff under the PSLRA. But, on that point, the Court finds the decision in
Other courts have disagreed with a per se approach.
The Court is persuaded by the argument made by Rice and James that there is a conflict between the direct action here and the derivative action in Delaware based on the issue of damages. Their argument is that:
("Mem. Opp. to IUOE") (ECF No. 50) (internal citations omitted). And, that argument is indeed correct in this case.
The Union tries to rebut this conflict not by denying its existence, but by explaining that, once the merger is consurrunated, the derivative action will disappear. Although it is true that derivative actions can often become direct actions post-merger,
The Union clearly stated in oral argument that "most of the time when there's a lead plaintiff appointed, that's not the original plaintiff, and the merger is not—does not have a set date yet, commonly what the parties stipulate to and the court orders is that the amended complaint be filed after the merger certain set days." (ECF No. 68). That proposed procedural scenario is troubling because this merger has been pending for several months, and recently another delay has been announced. Thus, it is unclear when, or if, a merger will be consummated. This action cannot sit on hold on the speculation that an already long-delayed merger may ultimately come to fruition or on the possibility that the Union will file an amended complaint that eliminates the present conflict.
The Court also finds persuasive the argument of Rice and James that the Union's 220 Action potentially serves as a basis to strengthen the Union's derivative case post-merger.
The Court cannot assess the adequacy of a lead plaintiff based on possible future events. The merger has not yet been consummated and the Court must analyze the conflict as it exists today. As of now, the derivative action is still pending and so too is the merger. Given the nature of the claims here and in the derivative action, there is a conflict. Furthermore, as Rice and James argue, the derivative action can continue post-merger. While the Court cannot now determine whether the derivative action here will succeed on that front, the conflict certainly is not speculative. On this record at this time, it is clear that the possibility of monetary recovery to the corporation in the derivative action is in direct contradiction to the class action here. Although it is possible, indeed likely, that this action will end in settlement, that is still not a certainty, and, in any event, the class plaintiffs here could seek rescissory damages under § 14(a). This conflict renders the Union an inadequate lead plaintiff. In other words, here, as in
The derivative action in Delaware alleges the breach of fiduciary duties on the part of nine directors and three executives. However, this class action "only involves a single schedule 14A Preliminary Proxy Statement and names ten director defendants, two of which are not named in the derivative action, and no executives." ("Mem. Opp. to IUOE") ((ECF No. 50) (emphasis added). As argued by Rice and James, these differences are significant because the PSLRA "reduces the liability for an individual defendant based on that defendant's percentage of fault compared to all parties that are arguably liable, whether or not named in the lawsuit."
On this record, the Court finds that the Union's conflicts are sufficient to rebut the lead plaintiff presumption.
It now is necessary to consider whether the movants (Rice and James) should be appointed as lead plaintiffs under the PSLRA. "Plaintiff Rice held and continues to hold 100 shares of Genworth common stock and Plaintiff James held and continues to hold at least 17, 123 shares of Genworth common stock." ("Mem. Law Support Lead Plnt.") (ECF No. 40). The movants, of the shareholders involved in these motions, therefore hold the second largest financial interest in the Company and thus are presumed to be the most adequate lead plaintiff.
The lead plaintiff is empowered under the PSLRA to select and retain counsel to represent the class members in the consolidated actions.
The Court notes that the current case is a situation where the appointment of more than one plaintiff is appropriate. "[T] he statute allows the lead plaintiff to be a `person or group of persons' or class `member or group of members,' 15 U.S.C. § 78u-4(a)(3)(B)(i), (iii)(I). . . ."
"There is, however, some question whether two law firms should be allowed to serve as co-lead counsel." In re
For the foregoing reasons, the MOTION OF THE INTERNATIONAL UNION OF OPERATING ENGINEERS LOCAL NO. 478 PENSION FUND, RICHARD L. SALBERG, AND DAVID PINKOSKI FOR APPOINTMENT AS LEAD PLAINTIFFS AND APPROVAL OF THEIR SELECTION OF CO-LEAD COUNSEL (ECF No. 37) will be denied and PLAINTIFFS' MOTION FOR APPOINTMENT OF LEAD PLAINTIFFS AND COUNSEL (ECF No. 39) will be granted.
It is so ORDERED.
"The Proxy Statement fails to expressly indicate whether or not the standstill provisions contained in the confidentiality agreements entered into with any of the Interested Parties contained a "fall-away" provision that allows each of the Interested Parties to submit a superior proposal to acquire the Company." (Compl. ¶ 82).
"Goldman Sachs and Lazard must disclose whether they, any of their affiliates and/or related entities and/or any individual employees of Goldman Sachs and Lazard that were members of the team working on the Genworth account (as described in the "Background" section of the Proxy Statement), held and/or owned any type of security interest in Genworth, China Oceanwide and/or Asia Pacific and/or any affiliated entities." (Compl. ¶ 83).
"The Proxy Statement provides that the Board reviewed and considered the Certain Genworth Unaudited Financial Projections and also that both Goldman Sachs and Lazard utilized these projections and/or certain line item financial measure in rendering their fairness opinions. Specifically, in reconciling the Non-GAAP projected financial measures with the GAAP financial measures, as expressly required to do under Regulation G (17 C. F. R. §244. 100 et seq.), Defendants failed to disclose and/or define "accumulated other comprehensive income (loss), which financial measure was expressly used and omitted in calculating and projecting Genworth stockholder equity (Proxy Statement, 91), GAAP return on equity ("ROE"), and non-GAAP Operating ROE. Proxy Statement, 92, notes 3 and 4 respectively." (Compl. ¶ 84). "[T] he Proxy Statement provides a materially incomplete and misleading summary of the key financial analyses Goldman Sachs and Lazard performed in support of their fairness opinions." (Compl. ¶ 85).
On February 14, 2017, Defendants filed a motion to vacate the Delaware Court's February 13 Order on the grounds that, when the Rosenfeld Family Trust requested expedited relief, it failed to inform the Delaware Court about the existence of the earlierfiled Virginia Actions. The Delaware Court granted Defendants' motion and vacated the February 13 Order. Thereafter, on February 14 and February 15, 2017, Defendants filed motions to transfer each of the Delaware Actions to this Court or, in the alternative, to stay them pending resolution of the Virginia Actions.